Clinical trial / 2008
Daily DHEA supplementation for one year showed no benefit on cognitive performance or quality of life in healthy older adults.
A double-blind trial evaluated the effects of 50 mg daily oral DHEA versus placebo for 1 year in 225 healthy older adults. There were no differences between the DHEA and placebo groups in change over time in cognitive function (P > .10). Over time, BDI scores decreased for men (P = .006) and women (P = .02), and Satisfaction with Life Scale scores increased for women (P = .004), but no differences were observed between the DHEA and placebo groups on these measures, the SF-36, the Life Satisfaction Index-Z scale, or sexual function scales (P > .10).
- Study type
- Double-blind, randomized, controlled clinical trial
- Who was studied
- 110 men and 115 women aged 55 to 85 (mean ± standard deviation 68 ± 8)
- What was measured
- Cognitive function, depression (BDI), quality of life (SF-36, life satisfaction scales), and sexual function
THE PAPER
Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial.
Kritz-Silverstein D, von Mühlen D, Laughlin GA, Bettencourt R. J Am Geriatr Soc, 2008.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.